Gsa Capital Partners LLP Jazz Pharmaceuticals PLC Transaction History

Gsa Capital Partners LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$114.26 - $136.0 $192,985 - $229,704	1,689 New	1,689 $207,000
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $249,777 - $300,059	2,039 New	2,039 $252,000
Q2 2022 Aug 09, 2022	SELL	$141.59 - $168.66 $613,509 - $730,803	-4,333 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$129.64 - $160.7 $561,730 - $696,313	4,333 New	4,333 $675,000
Q2 2020 Aug 11, 2020	SELL	$95.68 - $121.88 $282,256 - $359,546	-2,950 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$87.74 - $152.74 $36,148 - $62,928	412 Added 16.23%	2,950 $294,000
Q4 2019 Feb 12, 2020	BUY	$117.65 - $153.73 $7,529 - $9,838	64 Added 2.59%	2,538 $379,000
Q3 2019 Nov 12, 2019	SELL	$125.18 - $143.24 $353,758 - $404,796	-2,826 Reduced 53.32%	2,474 $317,000
Q2 2019 Aug 06, 2019	BUY	$125.55 - $144.48 $665,415 - $765,744	5,300 New	5,300 $756,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $405,627 - $476,023	-3,330 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$115.94 - $166.74 $386,080 - $555,244	3,330 New	3,330 $413,000
Q2 2018 Aug 09, 2018	SELL	$146.33 - $183.18 $302,464 - $378,633	-2,067 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$135.59 - $157.16 $280,264 - $324,849	2,067 New	2,067 $312,000

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.95B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.